Increased risk of mortality from COVID-19 in people with obesity

Ana Cristina Ribeiro; Priscila Poli; Silvia Carla da Silva André Uehara

doi:10.15253/2175-6783.20232481453

Authors

Ana Cristina Ribeiro Universidade Federal de São Carlos https://orcid.org/0000-0002-0493-8376
Priscila Poli Universidade Federal de São Carlos https://orcid.org/0000-0002-8090-9403
Silvia Carla da Silva André Uehara Universidade Federal de São Carlos https://orcid.org/0000-0002-0236-5025

DOI:

https://doi.org/10.15253/2175-6783.20232481453

Keywords:

COVID-19; Obesity; Mortality; Risk Factors.

Abstract

Objective: to analyze the risk of mortality from COVID-19 in people with obesity. Methods: observational, retrospective, and analytical study. Data were collected in the State System of Data Analysis. For the comparative analysis of people with and without obesity, n=168,808 was adopted. The analyses were performed using the log-binomial regression model and relative risk calculation. The comparative model was adjusted for sex, age group, heart disease and diabetes. Results: in more than 95% of COVID-19 notifications, information regarding the risk factor obesity was recorded as ignored. Obese individuals with COVID-19 had 26% higher risk of death when compared to those without obesity. Obese individuals in the 11 to 60 age groups had the highest mortality risks compared to individuals without obesity. Obese women in the age groups 31 to 50 years and elderly women over 71 years had the lowest mortality risk when compared to obese men. Conclusion: obese people, especially adults, have an increased risk of mortality from COVID-19. Contributions to practice: to help establish public health strategies to identify the profiles of individuals considered at high risk in the SARS-CoV-2 pandemic.

References

Yoon J. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on national health insurance service health checkup data 2006-2015. J Obes Metab Syndr 2018;27:46-52. doi: https://dx.doi.org/10.7570/jomes.2018.27.3.195

Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa Nacional de Saúde 2019: atenção primária à saúde e informações antropométricas [Internet]. 2020 [cited Aug 29, 2022]. Available from: https://biblioteca.ibge.gov.br/visualizacao/livros/liv101758.pdf

Bliss ES, Whiteside E. The gut-brain axis, the human gut microbiota and their integration in the development of obesity. Front Physiol. 2018;9:900. doi: https://doi.org/10.3389/fphys.2018.00900

Nogueira-de-Almeida CA, Del Ciampo LA, Ferraz IS, Del Ciampo IRL, Contini AA, Ued FDV. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020;96(5):546-8. doi: https://doi.org/10.1016/j.jped.2020.07.001

Poly TN, Islam MM, Yang HC, Lin MC, Jian WS, Hsu MH, et al. Obesity and mortality among patients diagnosed with COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:620044. doi: https://dx.doi.org/10.3389/fmed.2021.62004

Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: a systematic review and meta-analysis. J Med Virol. 2021;93(1):257-61. doi: https://doi.org/10.1002/jmv.26237

Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020;28(7):1195-9. doi: http://doi.org/10.1002/oby.22831

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71(15):896-7. doi: https://doi.org/10.1093/cid/ciaa415

Souza FSH, Hojo-Souza NS, Batista BDO, Silva CM, Guidoni DL. On the analysis of mortality risk factors for hospitalized COVID-19 patients: a data-driven study using the major Brazilian database. PLoS One. 2021;16(3):e0248580. doi: https://doi.org/10.1371/journal.pone.0248580

Fundação Sistema Estadual de Análise de Dados - SEADE. Boletim completo [Internet]. 2022 [ci- ted Apr 11, 2022]. Available from: https://www.seade.gov.br/coronavirus/#

Instituto Brasileiro de Geografia e Estatística (IBGE). População [Internet]. 2021 [cited Apr 2, 2022]. Available from: https://cidades.ibge.gov.br/brasil/sp/panorama

Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392-8. doi: https://doi.org/10.2337/dc20-0576

Du Y, Lv Y, Zha W, Zhou N, Hong X. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: a dose-response meta-analysis. Metabolism. 2021;117:154373. doi: https://doi.org/10.1016/j.metabol.2020.154373

Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications. 2021;35(3):107817. doi: http://dx.doi.org/10.1016/j.jdiacomp.2020.107817

Kim J, Nam JH. Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection. Int J Obes. 2020;44:1541-2. doi: https://dx.doi.org/10.1038/s41366-020-0602-y

Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond). 2020;20(4): e109-e113. doi: https://dx.doi.org/10.7861/clinmed.2020-0239

Cheng WA, Turner L, Marentes Ruiz CJ, Tanaka ML, Congrave-Wilson Z, Lee Y, et al. Clinical manifestations of COVID-19 differ by age and obesity status. Influenza Other Respir Viruses. 2022;16(2):255-64. doi: https://doi.org/10.1111/irv.12918

Emilsson V, Gudmundsson EF, Aspelund T, Jonsson BG, Gudjonsson A, Launer LJ, et al. Serum levels of ACE2 are higher in patients with obesity and diabetes. Obes Sci Pract. 2020;7(2):239-43. doi: https://doi.org/10.1002/osp4.472

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: http://doi.org/10.1056/NEJMoa2002032

Abdolmaleki G, Taheri MA, Paridehpour S, Mohammadi NM, Tabatabaei YA, Mousavi T, et al. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines. Daru J Pharm Sci. 2022;1-28. doi: https://doi.org/10.1007/s40199-022-00446-8

Nakeshbandi M, Maini R, Daniel P, Rosengarten S, Parmar P, Wilson C, et al. The impact of obesity on COVID-19 complications: a retrospective cohort study. Int J Obes (Lond). 2020;44(9):1832-7. doi: https://doi.org/10.1038/s41366-020-0648-x

Brandi ML. Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? Rev Endocr Metab Disord. 2022;23(2):171-83. https://dx.doi.org/10.1007/s11154-021-09692-8

Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13(1):2. https://doi.org/10.1186/s40246-018-0185-z

Shepherd R, Cheung AS, Pang K, Saffery R, Novakovic B. Sexual dimorphism in innate immunity: the role of sex hormones and epigenetics. Front Immunol. 2021;11:604000. doi: https://doi.org/10.3389/fimmu.2020.604000

Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, et al. Potential influence of menstrual status and sex hormones on female severe acute respiratory syndrome coronavirus 2 infection: a cross-sectional multicenter study in Wuhan, China. Clin Infect Dis. 2021;72(9):e240-e248. doi: https://doi.org/10.1093/cid/ciaa1022

Halpern B, Louzada MLDC, Aschner P, Gerchman F, Brajkovich I, Faria-Neto JR, et al. Obesity and COVID-19 in Latin America: a tragedy of two pandemics-official document of the Latin American Federation of Obesity Societies. Obes Rev. 2021;22(3):e13165. doi: https://doi.org/10.1111/obr.13165

Bhaskaran K, Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of the BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet. 2018;6(12):944-53. doi: https://dx.doi.org/10.1016/S2213-8587(18)30288-2

Al-Bari MAA, Hossain S, Zahan MK. Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population. World J Radiol. 2021;13(1):1-18. doi: https://doi.org/10.4329/wjr.v13.i1.1

Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 infection, progression, and vaccination: focus on obesity and related metabolic disturbances. Obes Rev. 2021;22(10):e13313. doi: https://doi.org/10.1111/obr.13313

Siqueira PC, Cola JP, Comerio T, Sales CMM, Maciel EL. Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil. J Bras Pneumol. 2022;48(2):e20210401. doi: https://dx.doi.org/10.36416/1806-3756/e20210401